Autologous Human Schwann Cell(United States Department of Defense)(Autologous Human Schwann Cell(United States Department of Defense))

概要

基本信息

药物类型

细胞疗法

别名-

靶点-

作用方式-

作用机制

细胞替代物

治疗领域

神经系统疾病其他疾病

在研适应症

臂丛神经损伤

非在研适应症-

原研机构

Defense Language Institute Foreign Language Center

在研机构

University of Miami

非在研机构-

权益机构-

最高研发阶段临床1期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

2

项与 Autologous Human Schwann Cell(United States Department of Defense) 相关的临床试验

NCT02510079

/ No longer availableN/AIIT

Emergent Expanded Access to Use Autologous Human Schwann Cell Augmentation of Nerve Autograft Repair in a Single Patient With Severe Peripheral Nerve Injury

The primary purpose of this research study is to determine the safety of injecting ones own Schwann cells to augment sural nerve autografts after a severe, non-lacerating injury to the sciatic nerve has occurred.

开始日期-

申办/合作机构

University of Miami

[+1]

NCT05541250

/ Recruiting临床1期IIT

Safety and Efficacy of Autologous Human Schwann Cell (ahSC) Augmentation in Severe Peripheral Nerve Injury (PNI)

The primary purpose of this research study is to evaluate the safety and possible harms of injecting one's own Schwann cells along with nerve auto-graft after a severe injury to a major nerve has occurred.

开始日期2023-05-04

申办/合作机构

University of Miami

[+1]

100 项与 Autologous Human Schwann Cell(United States Department of Defense) 相关的临床结果

登录后查看更多信息

100 项与 Autologous Human Schwann Cell(United States Department of Defense) 相关的转化医学

登录后查看更多信息

100 项与 Autologous Human Schwann Cell(United States Department of Defense) 相关的专利（医药）

登录后查看更多信息

100 项与 Autologous Human Schwann Cell(United States Department of Defense) 相关的药物交易

登录后查看更多信息